Opioid Receptor Agonist Market By Drugs, Application, Size, Share Industry Trends and Forecast to 2029

Opioids are a type of painkiller that works by acting on the neurological system. They're mostly utilized for anaesthetic and pain relief. An agonist is a pharmacological molecule that activates specific brain receptors. When only a small number of receptors are engaged, this agonist elicits a strong physiological/pharmacological response, indicating that the medication has high intrinsic activity. Fentanyl, morphine, dihydromorphinone, meperidine, oxycodone, and oxymorphone are all strong agonist opioids. Opioid receptors are G-protein-coupled inhibitors that are primarily found in peripheral tissues and interfere with opioid receptors' pain-signaling function. Agonists are pain relievers that function by binding opioid receptors and reducing pain experience.

The rise in the aviation sector is escalating the growth of opioid receptor agonist market. Data Bridge Market Research analyses that the opioid receptor agonist market will grow at a CAGR of 4.50% during the forecast period of 2022 to 2029.

Read more:
https://www.databridgemarketresearch.com/reports/global-opioid-receptor-agonist-market

Recent Development
In September 2020, Fujian Cancer Hospital introduced a phase III clinical trial to evaluate the efficiency and well-being of fentanyl patch patients with moderate cancer pain in opioid-naive patients.
In March 2020, Trevena Inc. received the U.S. Food and Drug Administration (FDA) approval for OLINVYK (oliceridine). It is an opioid agonist indicated in adults so as to manage acute pain.

Opioid Receptor Agonist Market Scope
The opioid receptor agonist market is segmented on the basis of drugs, receptor binding, indication, route of administration, end users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drugs
Fentanyl
Codeine
Morphine
Buprenorphine
Others
On the basis of drugs, the opioid receptor agonist market is segmented into fentanyl, codeine, morphine, buprenorphine and others.

Receptor Binding
Full Agonist
Partial Agonist
On the basis of receptor binding, the opioid receptor agonist market is segmented into full agonist, partial agonist.

Indication
Pain management
Cough Suppression
Diarrhoea suppression
others
On the basis of indication, the opioid receptor agonist market is segmented into pain management, cough suppression, diarrhea suppression and others.

Route of Administration
Intravenous
Subcutaneous
Others
On the basis of route of administration, the opioid receptor agonist market is segmented into oral, parenteral and others.

End Users
Hospitals
Homecare
Specialty Clinics
Others
On the basis of end users, the opioid receptor agonist market is segmented into hospitals, homecare, specialty clinics and others.

Distribution Channel
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy

More Links:

https://dbmrbuisness.blogspot.com/2023/07/global-wireless-brain-sensors-market.html

https://dbmrbuisness.blogspot.com/2023/07/global-bioartificial-organ.html

https://dbmrbuisness.blogspot.com/2023/07/global-healthcare-integration-solutions.html

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact Us:-
Data Bridge Market research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

This release was published on openPR.